Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Turnstone Biologics Corp. - Common Stock (NQ:TSBX)

0.3513 -0.0032 (-0.90%)
Streaming Delayed Price Updated: 3:53 PM EDT, Jul 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 186,331
Open 0.3500
Bid (Size) 0.3500 (80)
Ask (Size) 0.3545 (300)
Prev. Close 0.3545
Today's Range 0.3455 - 0.3548
52wk Range 0.2900 - 2.560
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GMS, TSBX, BGFV on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
Get insights into the top gainers and losers of Friday's after-hours session.
Discover the top movers in Friday's after-hours session and stay informed about the post-market dynamics. 
Via Chartmill

Performance

YTD
-34.6%
-34.6%
1 Month
-2.1%
-2.1%
3 Month
-3.8%
-3.8%
6 Month
-27.6%
-27.6%
1 Year
-85.2%
-85.2%

More News

Read More
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Carisma Therapeutics Inc. (Nasdaq - CARM), Guaranty Bancshares, Inc. (NYSE - GNTY), MRC Global Inc. (NYSE - MRC), Turnstone Biologics Corp. (Nasdaq - TSBX)
From Brodsky & Smith LLC
Via GlobeNewswire
Turnstone Biologics To Merge With Biotech Royalty Aggregator XOMA, But Retail Sentiment Slumps
Via Stocktwits
TSBX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Turnstone Biologics Corp. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Turnstone Biologics Corp. Enters into Agreement to be Acquired by XOMA Royalty Corporation for $0.34 in Cash Per Share Plus a Contingent Value Right
From XOMA Royalty Corporation; Turnstone Biologics Corp.
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Which stocks have an unusual volume on Wednesday?
Via Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Turnstone Biologics Corp. Reports First Quarter 2025 Financial Results and Provides Recent Corporate Highlights
From Turnstone Biologics Corp.
Via GlobeNewswire
Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2024 Financial Results
From Turnstone Biologics Corp.
Via GlobeNewswire
Turnstone Biologics Announces Plans to Explore Strategic Alternatives
From Turnstone Biologics Corp.
Via GlobeNewswire
Turnstone Biologics Corp. Reports Third Quarter 2024 Financial Results and Provides Recent Business Highlights
From Turnstone Biologics Corp.
Via GlobeNewswire
Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting
From Turnstone Biologics Corp.
Via GlobeNewswire
Turnstone Biologics Announces Strategic Restructuring to Prioritize Portfolio and Extend Financial Runway
From Turnstone Biologics Corp.
Via GlobeNewswire
Crude Oil Gains Over 1%; Alibaba Posts Weak Revenue
Via Benzinga
Nasdaq Jumps Over 2%; Walmart Earnings Top Views
Via Benzinga
Turnstone Biologics Shifts Focus To 'High Unmet Medical Need' Cancers, Shares Initial Data From Colorectal Cancer Cell Therapy Study
Via Benzinga
Dow Surges Over 500 Points; US Retail Sales Rise In July
Via Benzinga
Topics Stocks
Why Is Turnstone Biologics (TSBX) Stock Down 38% Today?
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
Why Lumentum Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket
Via Benzinga
TSBX Stock Earnings: Turnstone Biologics Misses EPS for Q2 2024
Via InvestorPlace
Turnstone Biologics Corp. Reports Second Quarter 2024 Financial Results and Provides Recent Business Highlights
From Turnstone Biologics Corp.
Via GlobeNewswire
Turnstone Biologics Corp. Reports Positive Initial Data from Phase 1 Trial of TIDAL-01 in Metastatic Colorectal Cancer
From Turnstone Biologics Corp.
Via GlobeNewswire

Frequently Asked Questions

Is Turnstone Biologics Corp. - Common Stock publicly traded?
Yes, Turnstone Biologics Corp. - Common Stock is publicly traded.
What exchange does Turnstone Biologics Corp. - Common Stock trade on?
Turnstone Biologics Corp. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Turnstone Biologics Corp. - Common Stock?
The ticker symbol for Turnstone Biologics Corp. - Common Stock is TSBX on the Nasdaq Stock Market
What is the current price of Turnstone Biologics Corp. - Common Stock?
The current price of Turnstone Biologics Corp. - Common Stock is 0.3513
When was Turnstone Biologics Corp. - Common Stock last traded?
The last trade of Turnstone Biologics Corp. - Common Stock was at 07/30/25 03:53 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback